Sept. 6 (Bloomberg) -- Seven-time Tour de France winner Lance Armstrong is considering a return to the event next year to answer allegations that he used performance-enhancing drugs during his career.
``While I'm absolutely enjoying my time as a retired athlete with (girlfriend) Sheryl (Crow) and the kids, the recent smear campaign out of France has awoken my competitive side,'' Armstrong said in a statement on his Web site. ``I'm not willing
to put a percentage on the chance, but I will no longer rule it out.''
Armstrong retired from cycling after winning the Tour in July. The French newspaper L'Equipe said last month that six of Armstrong's samples from the 1999 Tour showed traces of the banned hormone erythropoietin, or EPO.
Armstrong has denied the allegations and said on Aug. 26 he was considering legal action against the French newspaper. A run at an eighth Tour de France title would be the best way to get
back at the French, he told the Austin American-Statesman newspaper.
``While I'm absolutely enjoying my time as a retired athlete with (girlfriend) Sheryl (Crow) and the kids, the recent smear campaign out of France has awoken my competitive side,'' Armstrong said in a statement on his Web site. ``I'm not willing
to put a percentage on the chance, but I will no longer rule it out.''
Armstrong retired from cycling after winning the Tour in July. The French newspaper L'Equipe said last month that six of Armstrong's samples from the 1999 Tour showed traces of the banned hormone erythropoietin, or EPO.
Armstrong has denied the allegations and said on Aug. 26 he was considering legal action against the French newspaper. A run at an eighth Tour de France title would be the best way to get
back at the French, he told the Austin American-Statesman newspaper.